Home / Import refusals / AEK-9487351-8/10003/1

FDA Import Refusal AEK-9487351-8/10003/1 — Ipca Laboratories Limited

Ipca Laboratories Limited — FEI 3009105553

The FDA refused shipment AEK-9487351-8/10003/1 from Ipca Laboratories Limited (India) on March 9, 2026. The refused product falls under Drugs and Biologics — VALSARTAN (ANTI-HYPERTENSIVE - PART II). Cited charges: 118,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
March 9, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
62ODA12 VALSARTAN (ANTI-HYPERTENSIVE - PART II)
Charges
118,75

Other import refusals

  • 1FX-1615576-3/20002/4 (Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-3108687-6/30002/1 (Sat May 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-0770066-3/70003/1 (Fri Jan 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7840360-5/70003/1 (Thu Nov 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7708966-0/50003/1 (Wed Sep 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources